▲ Peaking
Business
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial
Roche's experimental GLP-1/GIP drug enicepatide delivers positive phase II results, cutting body weight and blood-sugar levels.
Enicepatide
1 trends tracked about this subject — the full history, oldest to newest below.